Pressure, trigger forces, and epinephrine auto-injectors

The recent article by Dreborg et al1 concluded that Emerade, defined as a low-pressure epinephrine auto-injector, has no risk of intraosseous injection in children and a low risk of subcutaneous injection in adolescents and adults. However, assumptions leading to these conclusions could be incorrect. (Source: Annals of Allergy, Asthma and Immunology)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2PthXcc